Avanos Medical (AVNS) Net Income towards Common Stockholders (2016 - 2024)
Historic Net Income towards Common Stockholders for Avanos Medical (AVNS) over the last 11 years, with Q3 2024 value amounting to -$1.6 million.
- Avanos Medical's Net Income towards Common Stockholders fell 13137.25% to -$1.6 million in Q3 2024 from the same period last year, while for Dec 2024 it was -$5.5 million, marking a year-over-year increase of 8940.27%. This contributed to the annual value of -$51.9 million for FY2023, which is 27896.55% down from last year.
- Per Avanos Medical's latest filing, its Net Income towards Common Stockholders stood at -$1.6 million for Q3 2024, which was down 13137.25% from -$2.5 million recorded in Q2 2024.
- Over the past 5 years, Avanos Medical's Net Income towards Common Stockholders peaked at $38.5 million during Q2 2021, and registered a low of -$63.8 million during Q2 2023.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$500000.0 (2023), whereas its average is -$4.9 million.
- Per our database at Business Quant, Avanos Medical's Net Income towards Common Stockholders skyrocketed by 138333.33% in 2021 and then plummeted by 92857.14% in 2023.
- Quarter analysis of 5 years shows Avanos Medical's Net Income towards Common Stockholders stood at -$49.0 million in 2020, then surged by 47.55% to -$25.7 million in 2021, then skyrocketed by 128.02% to $7.2 million in 2022, then plummeted by 106.94% to -$500000.0 in 2023, then plummeted by 220.0% to -$1.6 million in 2024.
- Its Net Income towards Common Stockholders stands at -$1.6 million for Q3 2024, versus -$2.5 million for Q2 2024 and -$1.4 million for Q1 2024.